Loading
Latest filing published 27 Feb 2009 for Targanta Therapeutics Corp..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Eric M. Gordon discloses dealings in Targanta Therapeutics Corp. to SEC (Form 4). Between 15 October 2007 and 25 February 2009, the trades on record add up to 9 filings.
Every open-market trade on record is a purchase: 3 purchases worth €2.8M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
A typical purchase (the median) is worth €688k.
Most recently, on 27 February 2009, the filings show a transaction in Targanta Therapeutics Corp. The clock since the last published purchase (17 October 2007) now reads 6,948 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations